Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Historia zmian
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · e77705356da7
- 22 Oct 2026 · 808ec68cae79
- 21 Oct 2026 · 643d3df46860
- 20 Oct 2026 · 94a883a660e5
- 19 Oct 2026 · 35a6094984e6
- 18 Oct 2026 · 5c224d57a5e1
- 17 Oct 2026 · 9af7cef030b7
- 16 Oct 2026 · 0f051739b82e
- 15 Oct 2026 · 0bce380c0079
- 14 Oct 2026 · c343d3ddae28
- 13 Oct 2026 · b221dcff8af6
- 12 Oct 2026 · 474322105b95
- 11 Oct 2026 · 6ec3445f2901
- 10 Oct 2026 · 1e3b7065e92f
- 09 Oct 2026 · 6b13a17fa59b
- 08 Oct 2026 · a2ce10888893
- 07 Oct 2026 · e42c715d4fda
- 06 Oct 2026 · c343d3ddae28
- 05 Oct 2026 · cde23ab87af9
- 04 Oct 2026 · ec798e27ad64